Skip to Content
Merck
CN

MT17MAG47K-PX25

MILLIPLEX® Mouse TH17 Panel

Premixed Mouse Th17 25-Plex Panel

Synonym(s):

mouse Th17 panel, murine Th17 assay

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12161503
NACRES:
NA.47
eCl@ss:
32161000
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

MILLIPLEX® Mouse TH17 Panel,

species reactivity

mouse

Quality Level

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

assay range

accuracy: 85-110%, linearity: 111.0%
(1:04), linearity: 113.1%
(1:08), standard curve range: 1.5-1,500 pg/mL
(IL-4), standard curve range: 10-10,000 pg/mL
(IL-17F), standard curve range: 127-130,000 pg/mL
(IL-28B), standard curve range: 15-15,000 pg/mL
(IL-1β), standard curve range: 2.4-2,500 pg/mL
(IL-22), standard curve range: 20-20,000 pg/mL
(IL-10, IL-12(p70), & IL-21), standard curve range: 3.4-3,500 pg/mL
(TNFα), standard curve range: 34-35,000 pg/mL
(GM-CSF & IL-15), standard curve range: 342-350,000 pg/mL
(IL-23), standard curve range: 39-40,000 pg/mL
(IL-13 & IL-17A), standard curve range: 4.9-5,000 pg/mL
(IL-5), standard curve range: 488-500,000 pg/mL
(TNFβ), standard curve range: 49-50,000 pg/mL
(CD40L IL-31 & MIP-3α), standard curve range: 586-600,000 pg/mL
(IL-17E/ IL-25), standard curve range: 6.9-6,000 pg/mL
(IL-2), standard curve range: 7.8-8,000 pg/mL
(IFNγ & IL-6), standard curve range: 78-80,000 pg/mL
(IL-33), standard curve range: 879-900,000 pg/mL
(IL-27)

technique(s)

multiplexing: suitable

input

plasma
serum
cell culture supernatant(s)

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Th17 cells, a subset of CD4+ T helper cells, play a crucial role in immune responses by producing a range of cytokines, particularly interleukin-17 (IL-17). In mice, Th17 cytokines, including IL-17A, IL-17F, and IL-22, are involved in promoting inflammation and are key players in the defense against extracellular pathogens, as well as in the pathogenesis of autoimmune diseases. These cytokines help to recruit neutrophils and enhance the production of antimicrobial peptides, contributing to the host′s immune response.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze 25 analytes in mouse serum, plasma, and cell culture supernatants.

Analytes included: CD40 Ligand, GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 (p70), IL-13, IL-15, IL-17A, IL-17E/IL-25, IL-17F, IL-21, IL-22, IL-23, IL-27, IL-28B, IL-31, IL-33, MIP-3α/CCL20, TNF-α, TNFβ

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

Expanded Th17 Cytokine Coverage: Detects a broad spectrum of Th17-associated cytokines and chemokines such as IL-17A, IL-17F, IL-21, IL-22, and IL-23—ideal for dissecting immune pathways in autoimmune and inflammatory conditions.

Low Sample Volume Requirement: Designed for use with minimal sample input, making it highly suitable for mouse models and studies with limited biological material.

High-Throughput Multiplexing via Luminex® Technology: Utilizes magnetic bead-based multiplexing to analyze multiple targets in a single well, reducing reagent use and increasing lab efficiency.

Mouse-Specific Verification: Optimized for mouse serum, plasma, and cell culture supernatants to ensure reliable performance in preclinical research.

Tailored for Autoimmune and Oncology Applications: Supports investigations into Th17 cell involvement in diseases such as arthritis, Crohn’s disease, diabetes, and cancer.

Legal Information

Luminex is a registered trademark of Luminex Corporation
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.


Still not finding the right product?

Explore all of our products under MILLIPLEX® Mouse TH17 Panel


signalword

Danger

target_organs

Respiratory Tract

Storage Class

10 - Combustible liquids

wgk

WGK 3

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 2

Regulatory Information

新产品

This item has



Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Sansana Sawasdikosol et al.
ImmunoHorizons, 4(7), 382-391 (2020-07-08)
Hematopoietic progenitor kinase 1 (HPK1) is a negative regulator of TCR-initiated signal transduction. Both the HPK1-/- mice and the genetically engineered mice with a point mutation that disrupts the catalytic activity of HPK1 possess enhanced antitumor immunity, especially when these
Mab Pereira Corrêa et al.
Journal of molecular medicine (Berlin, Germany), 95(9), 1005-1015 (2017-07-01)
Atopic dermatitis (AD) is caused by both dysregulated immune responses and an impaired skin barrier. Although beta-galactoside-binding protein galectin-1 (Gal-1) has immunomodulatory effects in several inflammatory disorders, therapeutic strategies based on its anti-inflammatory properties have not been explored in AD.
Lirong Li et al.
Scientific reports, 6, 37894-37894 (2016-12-03)
Mesenchymal stem cells (MSCs) transplantation is a promising therapeutic strategy for type 1 diabetes (T1D). However, little is known on whether MSC transplantation can benefit T1D patients with ketoacidosis and its potential actions. Here, we show that infusion with bone